China Targeted Therapeutics Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Targeted Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astrazeneca

    • Abbvie

    • Amgen Inc

    • Glaxosmithkline PLC

    • Bristol-Myers Squibb

    • ELI Lilly

    • Novartis International AG

    • F Hoffmann-La Roche AG

    • Merck & Co, Inc

    By Type:

    • Cell Therapy

    • Others

    • Oncology Drugs

    • Monoclonal Antibodies

    • Immunotherapy

    By Application:

    • Senior Age

    • Middle Age

    • Pediatrics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Targeted Therapeutics Market Overview 2018-2029

    • 1.1 China Targeted Therapeutics Industry Development Overview

    • 1.2 China Targeted Therapeutics Industry Development History

    • 1.3 China Targeted Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Targeted Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Cell Therapy (2018-2029)

      • 1.4.2 China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Oncology Drugs (2018-2029)

      • 1.4.4 China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.5 China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • 1.5 China Targeted Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Senior Age (2018-2029)

      • 1.5.2 China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Middle Age (2018-2029)

      • 1.5.3 China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

    • 1.6 China Targeted Therapeutics Market Analysis by Region

      • 1.6.1 North China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Targeted Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Targeted Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Targeted Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Targeted Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Targeted Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Targeted Therapeutics Industry Development

    Chapter 3 Targeted TherapeuticsIndustry Chain Analysis

    • 3.1 Targeted Therapeutics Industry Chain

    • 3.2 Targeted Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Targeted Therapeutics Market

    • 3.3 Targeted Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Targeted Therapeutics Market

    Chapter 4 China Targeted Therapeutics Market, by Type

    • 4.1 China Targeted Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Targeted Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Targeted Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Targeted Therapeutics Production Volume and Growth Rate of Cell Therapy

      • 4.5.2 China Targeted Therapeutics Production Volume and Growth Rate of Others

      • 4.5.3 China Targeted Therapeutics Production Volume and Growth Rate of Oncology Drugs

      • 4.5.4 China Targeted Therapeutics Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.5 China Targeted Therapeutics Production Volume and Growth Rate of Immunotherapy

    Chapter 5 China Targeted Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Targeted Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Targeted Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Targeted Therapeutics Market Size and Growth Rate of Senior Age

      • 5.5.2 China Targeted Therapeutics Market Size and Growth Rate of Middle Age

      • 5.5.3 China Targeted Therapeutics Market Size and Growth Rate of Pediatrics

    Chapter 6 China Targeted Therapeutics Market, by Region

    • 6.1 China Targeted Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Targeted Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Targeted Therapeutics Market Analysis

    • 7.1 North China Targeted Therapeutics Market, by Type

    • 7.2 North China Targeted Therapeutics Market, by Application

    Chapter 8 Central China Targeted Therapeutics Market Analysis

    • 8.1 Central China Targeted Therapeutics Market, by Type

    • 8.2 Central China Targeted Therapeutics Market, by Application

    Chapter 9 South China Targeted Therapeutics Market Analysis

    • 9.1 South China Targeted Therapeutics Market, by Type

    • 9.2 South China Targeted Therapeutics Market, by Application

    Chapter 10 East China Targeted Therapeutics Market Analysis

    • 10.1 East China Targeted Therapeutics Market, by Type

    • 10.2 East China Targeted Therapeutics Market, by Application

    Chapter 11 Northeast China Targeted Therapeutics Market Analysis

    • 11.1 Northeast China Targeted Therapeutics Market, by Type

    • 11.2 Northeast China Targeted Therapeutics Market, by Application

    Chapter 12 Southwest China Targeted Therapeutics Market Analysis

    • 12.1 Southwest China Targeted Therapeutics Market, by Type

    • 12.2 Southwest China Targeted Therapeutics Market, by Application

    Chapter 13 Northwest China Targeted Therapeutics Market Analysis

    • 13.1 Northwest China Targeted Therapeutics Market, by Type

    • 13.2 Northwest China Targeted Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astrazeneca

        • 14.1.1 Astrazeneca Company Profile

        • 14.1.2 Astrazeneca Targeted Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Abbvie

        • 14.2.1 Abbvie Company Profile

        • 14.2.2 Abbvie Targeted Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Amgen Inc

        • 14.3.1 Amgen Inc Company Profile

        • 14.3.2 Amgen Inc Targeted Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Glaxosmithkline PLC

        • 14.4.1 Glaxosmithkline PLC Company Profile

        • 14.4.2 Glaxosmithkline PLC Targeted Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bristol-Myers Squibb

        • 14.5.1 Bristol-Myers Squibb Company Profile

        • 14.5.2 Bristol-Myers Squibb Targeted Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 ELI Lilly

        • 14.6.1 ELI Lilly Company Profile

        • 14.6.2 ELI Lilly Targeted Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis International AG

        • 14.7.1 Novartis International AG Company Profile

        • 14.7.2 Novartis International AG Targeted Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 F Hoffmann-La Roche AG

        • 14.8.1 F Hoffmann-La Roche AG Company Profile

        • 14.8.2 F Hoffmann-La Roche AG Targeted Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Merck & Co, Inc

        • 14.9.1 Merck & Co, Inc Company Profile

        • 14.9.2 Merck & Co, Inc Targeted Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Targeted Therapeutics Industry Research Conclusions

    • 15.2 Targeted Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Targeted Therapeutics Industry Market Size (2018-2029)

    • Figure China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Cell Therapy (2018-2029)

    • Figure China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Oncology Drugs (2018-2029)

    • Figure China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Targeted Therapeutics Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Senior Age (2018-2029)

    • Figure China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Middle Age (2018-2029)

    • Figure China Targeted Therapeutics Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

    • Figure North China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Targeted Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Targeted Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Targeted Therapeutics Market Share by Type in 2018

    • Figure China Targeted Therapeutics Market Share by Type in 2023

    • Figure China Targeted Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Targeted Therapeutics Production Volume and Growth Rate of Cell Therapy (2018-2023)

    • Figure China Targeted Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Targeted Therapeutics Production Volume and Growth Rate of Oncology Drugs (2018-2023)

    • Figure China Targeted Therapeutics Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Targeted Therapeutics Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Targeted Therapeutics Market Share by Application in 2018

    • Figure China Targeted Therapeutics Market Share by Application in 2023

    • Figure China Targeted Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Targeted Therapeutics Market Size and Growth Rate of Senior Age (2018-2023)

    • Figure China Targeted Therapeutics Market Size and Growth Rate of Middle Age (2018-2023)

    • Figure China Targeted Therapeutics Market Size and Growth Rate of Pediatrics (2018-2023)

    • Table China Targeted Therapeutics Production Volume by Region (2018-2023)

    • Table China Targeted Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Targeted Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Targeted Therapeutics Production Value by Region (2018-2023)

    • Table China Targeted Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Targeted Therapeutics Production Value Share by Region (2018-2023)

    • Table China Targeted Therapeutics Sales Volume by Region (2018-2023)

    • Table China Targeted Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Targeted Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Targeted Therapeutics Sales Value by Region (2018-2023)

    • Table China Targeted Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Targeted Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table North China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table South China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table East China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Targeted Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Targeted Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Targeted Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Targeted Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Astrazeneca Company Profile

    • Table Astrazeneca Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Abbvie Company Profile

    • Table Abbvie Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Glaxosmithkline PLC Company Profile

    • Table Glaxosmithkline PLC Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table ELI Lilly Company Profile

    • Table ELI Lilly Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Targeted Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Targeted Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.